Navigation Links
Addrenex Pharmaceuticals' New Hires Further Company Goal to Identify New Drugs for Adrenergic Regulation
Date:8/19/2008

DURHAM, N.C., Aug. 19 /PRNewswire/ -- Addrenex Pharmaceuticals ( http://www.addrenex.com ) has made three strategic hires this month to further its goal of identifying and developing as many new drug candidates as possible over the next 18 months.

The fast-paced timeline they have set for drug discovery mirrors the company's recent successes in developing two new drugs, Clonicel(R) for attention deficit/hyperactivity disorder and CloniBID for hypertension, over the past two years. A new drug application has already been filed for CloniBID, with Food and Drug Administration review expected by December 2008, and Clonicel is in phase 3 clinical trials. Commercial rights to both drugs have been granted to Atlanta-based Sciele Pharma.

The additions of Steven Butts, M.B.A., as vice president of commercial operations and Gary Bream, Ph.D., as senior director of scientific affairs will strengthen Addrenex's ability to pursue additional drugs to treat conditions such as menopausal flushing, pain, addiction, aggression, and post traumatic stress disorder, said Moise Khayrallah, Ph.D., cofounder and chief executive officer of Addrenex. Yuki Prescott has also joined as clinical trials manager and will enhance the clinical team's ability to oversee a growing clinical program.

"We now have a solid partnership in place with Sciele that will enable us to develop our lead compounds and to pursue additional compounds in our portfolio that target the alpha-2 adrenergic receptors," said Khayrallah. "We're using our lead compounds to power the rest of the portfolio. The highly skilled team we have now assembled gives us the capability to deliver on our commitments and meet our fast-paced timelines."

The indications being targeted by Addrenex are each associated with an overactive adrenergic system, a group of hormones produced by the adrenal glands that regulate the body's reaction to stress, hormonal
'/>"/>

SOURCE Addrenex Pharmaceuticals
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Vion Pharmaceuticals Enters Into Agreement With HOVON to Conduct a Phase III Clinical Trial of Cloretazine(R) in Combination With Frontline AML and MDS Therapy
2. Oramed Pharmaceuticals Chosen to Present Oral Insulin Trial Results at EASD Conference (September 7-11, Rome)
3. Peregrine Pharmaceuticals Doses First Patient in Phase II Trial of Bavituximab in Patients With Advanced Breast Cancer
4. Oramed Pharmaceuticals Announces Successful Phase 2A Clinical Trial of its Oral Insulin Capsule
5. Rib-X Pharmaceuticals, Inc. Announces Recent and Upcoming Presentations at Scientific Conferences
6. Oramed Pharmaceuticals to Hold Conference Call on August 6 to Present Results of Phase 2A Oral Insulin Capsule Clinical Trials
7. Quark Pharmaceuticals Announces First Patient Dosing by Pfizer in Phase II Trial of RNAi Therapy in Diabetic Macular Edema
8. Idenix Pharmaceuticals Advances HCV Discovery Program to Clinic
9. Celator Pharmaceuticals Raises Series C Financing in Excess of $22.5 Million
10. Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Second Quarter 2008 Financial Results and Provide a Clinical Program Update on August 7, 2008
11. Sound Pharmaceuticals Files Second IND with the FDA for the Prevention of Chemotherapy Induced Hearing Loss in Advanced Stage Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... 2014 Today, iHealth Lab Inc. announced it has ... for its first institutional round of funding. The strategic ... reach, accelerate growth and innovation, and invest in additional ... Xiaomi Ventures will join iHealth,s board of directors, bringing ... ecommerce. "We are very pleased to have ...
(Date:9/19/2014)... , September 19, 2014 ... has announced the addition of the ... to their offering.      (Logo: ... been broadly classified into wide categories based ... for the treatment of different gynecological conditions ...
(Date:9/19/2014)... Ill. , Sept. 19, 2014  The board ... ) declared a quarterly cash dividend of $0.42 per ... Nov. 17, 2014 to stockholders of record at the ... About AbbVie AbbVie is a global, research-based biopharmaceutical company ... mission is to use its expertise, dedicated people and ...
Breaking Medicine Technology:iHealth Raises $25 Million to Fuel Growth and Global Market Share 2Global Gynecological Devices Market 2014-2018: Key Vendors are Bayer, Boston Scientific, CooperSurgical, Ethicon, Hologic, Medtronic, Olympus and Stryker 2Global Gynecological Devices Market 2014-2018: Key Vendors are Bayer, Boston Scientific, CooperSurgical, Ethicon, Hologic, Medtronic, Olympus and Stryker 3
... 2011 Reportlinker.com announces that a new market ... Global Microscopes Industry ... the worldwide markets for Microscopes in US$ Million ... Microscopes, and Scanning Probe Microscopes. The report also ...
... StemCyte, Inc. announces the launch of www.cordbloodtv.com , ... offers this comprehensive educational tool that allows audiences worldwide ... blood banking options and the latest in medical research ... "StemCyte is pleased to offer our worldwide ...
Cached Medicine Technology:Reportlinker Adds Global Microscopes Industry 2Reportlinker Adds Global Microscopes Industry 3Reportlinker Adds Global Microscopes Industry 4Reportlinker Adds Global Microscopes Industry 5Reportlinker Adds Global Microscopes Industry 6Reportlinker Adds Global Microscopes Industry 7Reportlinker Adds Global Microscopes Industry 8Reportlinker Adds Global Microscopes Industry 9Reportlinker Adds Global Microscopes Industry 10Reportlinker Adds Global Microscopes Industry 11Reportlinker Adds Global Microscopes Industry 12Reportlinker Adds Global Microscopes Industry 13Reportlinker Adds Global Microscopes Industry 14Reportlinker Adds Global Microscopes Industry 15Reportlinker Adds Global Microscopes Industry 16Reportlinker Adds Global Microscopes Industry 17Reportlinker Adds Global Microscopes Industry 18Reportlinker Adds Global Microscopes Industry 19Reportlinker Adds Global Microscopes Industry 20Reportlinker Adds Global Microscopes Industry 21Reportlinker Adds Global Microscopes Industry 22StemCyte Launches CordBloodTV 2
(Date:9/20/2014)... 20, 2014 Ticket Down is ... tickets. This popular ticket exchange is offering their customer ... is nearing that next step in the entertainment business. The ... in the music and entertainment business, but is closing in ... straight No. 1 album, will hit the road next year ...
(Date:9/20/2014)... 19, 2014 (HealthDay News) -- The avian flu that ... could be spread through respiratory drops and therefore poses ... study. Although no human illnesses have been linked ... Children,s Research hospital have discovered natural mutations to the ... travel through the air in droplets. Current seasonal ...
(Date:9/20/2014)... York, New York (PRWEB) September 20, 2014 ... power morcellators ( http://www.injurybeacon.com/power-morcellator/ ) in gynecological ... that yet another insurer has announced plans to ... statement posted on its website last month, Harrisburg, ... procedures effective November 1, 2014. The insurer said ...
(Date:9/20/2014)... PA (PRWEB) September 20, 2014 "As a ... in their tanks," said an inventor from Tamaqua, Pa. "The ... mounted on the backs of their chairs. My invention enables ... developed the Kam Oxygen Sensor to make it easier to ... that the user knows when the tank is low. It ...
(Date:9/20/2014)... 2014 RBSEO Services, which has occupied ... has announced it provides an affordable website SEO (Search ... This announcement would benefit those new and old businesses ... cannot afford to pay a big amount for their ... their websites in top search results for their business ...
Breaking Medicine News(10 mins):Health News:Ariana Grande Tickets in Chicago/Rosemont, Kansas City, Milwaukee, Saint Paul, Dallas, Houston, San Antonio, Oklahoma City Go On Sale Today 2Health News:Ariana Grande Tickets in Chicago/Rosemont, Kansas City, Milwaukee, Saint Paul, Dallas, Houston, San Antonio, Oklahoma City Go On Sale Today 3Health News:Avian Flu In Harbor Seals Could Infect People 2Health News:As Power Morcellator Concerns Grow, Bernstein Liebhard LLP Notes Another Insurer’s Decision to Drop Coverage for Uterine Morcellation 2Health News:As Power Morcellator Concerns Grow, Bernstein Liebhard LLP Notes Another Insurer’s Decision to Drop Coverage for Uterine Morcellation 3Health News:RBSEO Services Announces Affordable Website SEO Service at Only $175 2
... CHICAGO Results of clinical research on new presbyopia treatments ... the United Stateswere reported in today,s Scientific Program of ... Ophthalmology (AAO) and Middle East-Africa Council of Ophthalmology ... comprehensive ophthalmic education conference and is in session October ...
... the world of business-performance experts and baseball talent scouts, ... to find a way to measure the productivity of ... findings the most recent issue of Science Translational ... contributions of individual scientists, judging the effectiveness of team ...
... By Serena Gordon HealthDay Reporter , MONDAY, ... average, untrained person can still save a life by focusing ... Heart Association. The simplified form of cardiopulmonary resuscitation, or ... -- and the oxygen in the blood -- flowing to ...
... HealthDay Reporter , MONDAY, Oct. 18 (HealthDay News) -- ... non-heart surgery had a higher risk of death in the ... found. And, patients who hadn,t been diagnosed with diabetes ... higher risk of death in the year after a surgical ...
... cancers can be divided into different subtypes based on ... protein to which the female hormone estrogen binds; that ... tumors have a worse outlook than those with ER-positive ... characterized as basal-like are the most aggressive and difficult ...
... American descent Latinas - from using cancer screening ... Dr. Linda Gallo from San Diego State University in ... are pessimistic about preventive health practices and disease outcomes ... breast and colorectal cancer. The research is published online ...
Cached Medicine News:Health News:New vision correction options for baby boomers 2Health News:New vision correction options for baby boomers 3Health News:New vision correction options for baby boomers 4Health News:Is team science productive? 2Health News:Is team science productive? 3Health News:New CPR Guidelines Emphasize Compressions First 2Health News:New CPR Guidelines Emphasize Compressions First 3Health News:Even Well-Controlled Diabetes May Present Post-Surgery Risk 2Health News:Even Well-Controlled Diabetes May Present Post-Surgery Risk 3Health News:Latinas: 'Cancer was just meant to be' 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: